Stockscreener 앱 받기
0.3905
2.38%
-0.0095
시간 외 거래:
.41
0.0195
+4.99%
전일 마감가:
$0.40
열려 있는:
$0.4
하루 거래량:
77,335
Relative Volume:
0.05
시가총액:
$2.81M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-18.19%
1개월 성능:
-9.92%
6개월 성능:
-37.22%
1년 성능:
-65.13%
1일 변동 폭
$0.385
$0.4087
1주일 범위
$0.361
$0.52
52주 변동 폭
$0.185
$1.27
Entero Therapeutics Inc Stock (ENTO) Company Profile
명칭
Entero Therapeutics Inc
전화
561-589-7020
주소
777 YAMATO ROAD, BOCA RATON
ENTO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
0.3905 | 2.81M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Entero Therapeutics Inc 주식(ENTO)의 최신 뉴스
Gastroparesis Pipeline Appears Robust With 8+ Key Pharma - openPR.com
Gastroparesis Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com
NuCana Stock Price, Quotes and Forecasts | NASDAQ:NCNA - Benzinga
More than 1 million power banks recalled after some consumers report fires - The Globe and Mail
FluroTech Ltd. Announces Change in Directors - TradingView
Thinkific Announces Closing of Secondary Offering of Approximately C$14.5 Million of Rhino Group's Shares - The Globe and Mail
Entero Therapeutics names Richard Paolone interim CEO - MSN
BMO Launches Human Capital Factor US Equity ETF - The Globe and Mail
Should You Buy Nio Stock Right Now? - The Globe and Mail
Celiac Disease Market Analysis 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Statistics, Revenue, Prevalence, Medication, Treatment Market and Companies by DelveInsight - The Globe and Mail
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Entero Therapeutics IncNow Offering 15.2 Million Shares Of Common Stock - marketscreener.com
Public market insider buying at Goldshore Resources (GSHR) - The Globe and Mail
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
Cattle Strength Pushes Triple Digit Gains at Midday - The Globe and Mail
New ETF Will Track The Holdings Of Investor Bill Ackman - The Globe and Mail
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
Entero Therapeutics, Inc. SEC 10-Q Report - TradingView
Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement - marketscreener.com
Entero Therapeutics Finalizes Settlement with Mattress Liquidators - TipRanks
Entero (ENTO) Announces Public Offering of 16.67 Million Shares - GuruFocus
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
MMM Earnings: 3M Warns of Tariff Impacts - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Entero Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa
Entero Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com
SNDL Announces Listing on the CSE - The Globe and Mail
Titan Environmental Solutions Inc. Appoints Edward J. Borkowski and Edward F. Feighan to its Board of Directors - The Manila Times
Strategic Board Shake-Up: Ex-Pharma CFO and Former Congressman Join Titan Environmental's Expansion Push - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - ACCESS Newswire
Entero Therapeutics Delays 10-K Filing - TipRanks
Celiac Disease Pipeline: Pioneering Progress with 25+ Leading - openPR.com
VOO ETF News, 4/1/2025 - The Globe and Mail
Tesla Inc. (TSLA) Stock Analysis & Analyst Coverage Update - The Globe and Mail
Entero Therapeutics Enters Rescission Deal to Unwind Merger With ImmunogenX - MarketScreener
Entero Therapeutics slips 7%, signs rescission agreement with ImmunogenX - MSN
Strategic Shift: Entero Therapeutics Unwinds Recent Merger and Strengthens Leadership - Stock Titan
Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC - Yahoo Finance
Micron (MU) Stock Trades Down, Here Is Why - The Globe and Mail
Johnson & Johnson plans $55 billion in US investments over the next four years - The Globe and Mail
Hogs Close with Weakness on Thursday - The Globe and Mail
Entero Therapeutics Inc (ENTO) 재무 분석
Entero Therapeutics Inc (ENTO)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Entero Therapeutics Inc 주식 (ENTO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Romano Sarah | Chief Financial Officer |
Oct 09 '24 |
Sale |
0.45 |
476 |
212 |
18,014 |
| Romano Sarah | Chief Financial Officer |
Jul 02 '24 |
Sale |
1.07 |
621 |
664 |
18,490 |
| SAPIRSTEIN JAMES | Chairman and CEO |
Jul 02 '24 |
Sale |
1.07 |
1,289 |
1,379 |
35,816 |
0.39%
0.42%
자본화:
|
볼륨(24시간):